US OptionsDetailed Quotes
APLS240816C35000
- 2.25
- -1.25-35.71%
15min DelayClose Aug 16 16:00 ET
2.55High2.25Low
2.25Open3.50Pre Close5 Volume196 Open Interest35.00Strike Price1.22KTurnover0.00%IV0.00%PremiumAug 16, 2024Expiry Date2.25Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma18.63Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Apellis Pharmaceuticals Stock Discussion
Sign in to post a comment
$Emergent BioSolutions (EBS.US)$👀 big news out WHO Says Expert Committee Will Propose Adopti - moomoo $Apellis Pharmaceuticals (APLS.US)$ $Puma Biotechnology (PBYI.US)$ $Novocure (NVCR.US)$
1
$Apellis Pharmaceuticals (APLS.US)$ CORRECTION: Apellis Pharmaceuticals Q2 2024 GAAP EPS $(0.30) Beats $(0.32) Estimate, Sales $199.70M Beat $191.51M Estimate
2
$Apellis Pharmaceuticals (APLS.US)$ 🥱 as i was saying the other day
1
4
2X 
$Apellis Pharmaceuticals (APLS.US)$ i made a lot of money on this stock
1
$Apellis Pharmaceuticals (APLS.US)$ I'm shocked this had not done anything. it hit bottom at 19.83 after the big scare panic sell off from mid 80s , bounce back up past 70. stupid corporate keeps selling off scaring investors. this is actually bargain price for this company
2
No comment yet
EZ_money OP : Vaccine developers for monkeypox include Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY), Emergent BioSolutions (EBS), and Chimerix (CMRX).